More than a year ago, Endpoints News made the decision that we needed a dedicated reporter covering the use of artificial ...

Novartis has terminated a mid-stage trial of an oral treatment candidate for idiopathic pulmonary fibrosis, the company ...

After flashing warning signs in July with only enough money for that month, Inventiva has now secured a lifeline to keep its ...

Danish drugmaker Lundbeck will buy La Jolla, CA-based Longboard Pharmaceuticals for $2.6 billion in cash, the companies said ...

Transgene’s therapeutic cancer vaccine candidate has failed a mid-stage test in certain HPV-driven cancers, sending its ...

Seven years ago, Daniel Ives believed that he was on the cusp of solving aging. He wanted to continue working on a discovery ...

Novo Holdings is set to buy one less facility from Catalent as the manufacturer has sold a facility in New Jersey to a ...

The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life ...

The FDA said it will reconsider the removal of Eli Lilly’s GLP-1 drug tirzepatide from its official shortage list, after a ...

Whew. Pfizer — after a week in which it began a showdown with an activist investor, was betrayed by and then reunited with ...

Generics giant Teva Pharmaceuticals will pay $450 million over six years to settle two allegations that the company violated ...

Sanofi has chosen US private equity firm Clayton, Dubilier & Rice to advance acquisition talks for its consumer health unit, ...